Vasostatin
Vasostatin (Chromogranin A N-terminal Fragment)
An N-terminal fragment of chromogranin A with vasodilatory and anti-angiogenic properties. Modulates cardiac function and vascular tone.
Mechanism of Action
Vasostatin inhibits endothelin-1-induced vasoconstriction, reduces cardiac contractility, and has anti-angiogenic properties. It modulates vascular tone through multiple mechanisms.
Health Claims & Evidence
Vasodilatory and anti-hypertensive effects
Modulates cardiac contractility
Anti-angiogenic properties
Short-Term Effects
Vasodilation, reduced cardiac contractility.
Long-Term Effects
Research use primarily.
Side Effects
Limited human data.
Contraindications
Limited human safety data.
This profile is provided for educational research only. It is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Verify primary sources and consult a qualified healthcare professional for medical decisions.
Research Papers
Vasostatin and vascular regulation
Tota et al. · Regulatory Peptides · 2003
Educational research only. This profile is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Consult a qualified healthcare professional for medical decisions.
Related Peptides
Explore the research further
Our AI Research Advisor can help you explore the evidence on Vasostatin and related peptides, and prepare an educational research summary.
Explore Research